NasdaqGS - Delayed Quote • USD
Sangamo Therapeutics, Inc. (SGMO)
At close: April 24 at 4:00 PM EDT
After hours: April 24 at 6:34 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 13.79M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| MACRAE SANDY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| DURAIBABU PRATHYUSHA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| WILLOUGHBY SCOTT B General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| DUBOIS-STRINGFELLOW NATHALIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| POOLER AMY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jan 22, 2024 |
| BIOGEN INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 0.68 per share. | Indirect | 4,060,800 | Sep 26, 2023 |
| PARKER H STEWART Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| MARKELS JOHN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| HORN MARGARET A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| MEYERS JAMES ROBERT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| CAREY ROBERT F. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| HILLAN KENNETH J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| SMITH KAREN L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| BEERS COURTNEY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 1, 2023 |
| MACRAE SANDY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2023 |
| DURAIBABU PRATHYUSHA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2023 |
| RAMELMEIER ROLF ANDREW Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2023 |
| MCCLUNG DAVID MARK Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2023 |
| FONTENOT JASON D PH.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2023 |
| WILLOUGHBY SCOTT B General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2023 |
| DUBOIS-STRINGFELLOW NATHALIE Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 24, 2023 |
| HORN MARGARET A Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 15, 2022 |
| BEERS COURTNEY Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Dec 15, 2022 |
| BIOGEN INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 5.27 - 5.33 per share. | Indirect | 2,657,240 | Aug 30, 2022 |
| MARKELS JOHN Director | Purchase at price 3.69 per share. | Direct | 25,029 | Jun 3, 2022 |
| PARKER H STEWART Director | Purchase at price 3.60 per share. | Direct | 17,996 | Jun 1, 2022 |
| PARKER H STEWART Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| MARKELS JOHN Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| RAMASASTRY SAIRA Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| MEYERS JAMES ROBERT Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| ZAKRZEWSKI JOSEPH S Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| CAREY ROBERT F. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| HILLAN KENNETH J. Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| SMITH KAREN L Director | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| MACRAE SANDY Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| DURAIBABU PRATHYUSHA Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| RAMELMEIER ROLF ANDREW Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| MCCLUNG DAVID MARK Chief Operating Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| SCHOTT ROBERT J. M.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| FONTENOT JASON D PH.D. Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| WILLOUGHBY SCOTT B General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Feb 25, 2022 |
| BIOGEN INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 8.51 per share. | Indirect | 23,522 | Dec 28, 2021 |
| BIOGEN INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 8.55 - 8.56 per share. | Indirect | 699,666 | Dec 27, 2021 |
| BIOGEN INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 8.56 per share. | Indirect | 202,541 | Dec 9, 2021 |
| BIOGEN INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 8.52 - 8.64 per share. | Indirect | 1,099,265 | Dec 8, 2021 |
| BIOGEN INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 8.51 - 8.52 per share. | Indirect | 22,166 | Dec 2, 2021 |
| BIOGEN INC. Beneficial Owner of more than 10% of a Class of Security | Sale at price 8.60 per share. | Indirect | 248,434 | Nov 26, 2021 |
| WILLOUGHBY SCOTT B General Counsel | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Aug 13, 2021 |
| DURAIBABU PRATHYUSHA Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Jun 11, 2021 |
| LOEB GARY General Counsel | Sale at price 13.10 - 13.18 per share. | Direct | 230,042 | Mar 23, 2021 |
Related Tickers
DTIL Precision BioSciences, Inc.
9.82
-4.01%
PRQR ProQR Therapeutics N.V.
2.0100
-0.50%
BLUE bluebird bio, Inc.
0.9229
-4.91%
ADAP Adaptimmune Therapeutics plc
1.0800
-5.26%
KPTI Karyopharm Therapeutics Inc.
1.0900
0.00%
TERN Terns Pharmaceuticals, Inc.
4.7500
+1.28%
LPTX Leap Therapeutics, Inc.
3.2900
+2.81%
NKTR Nektar Therapeutics
1.3800
-2.82%
XFOR X4 Pharmaceuticals, Inc.
1.2900
+4.88%
AGEN Agenus Inc.
7.42
+14.86%